American Journal on Addictions

Article	Citations
AAAP's Annual Meeting and Scientific Symposium	26
Issue Information	26
Stand against stigma	24
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression	23
Self assessment ad (002)	23
Issue Information	19
2024 Annual Meeting Posters	19
Call for Special Issue 2024	19
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States	15
AAAP 36th Annual Meeting & Scientific Symposium Save the Date	15
AAAP Stimulant Use Disorder PIP	14
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances	13
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021	13
Gender differences in circumstances associated with cannabis use	13
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada	12
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey	12
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment	12
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort	11
AAAP Annual meeting ad	10
Become a member of AAAP!	10
Issue Information	10
Narcotics Anonymous members in recovery from methamphetamine use disorder	10
Correlates of optimism among patients in substance use disorder inpatient treatment	9
Identifying factors associated with peer recovery coach interactions and successful outcomes for patients with opioid use disorder in Southern West Virginia	9
Call for Special Issue Papers 2025	9

Call for Review Papers 2024	9
Call for Review Papers 2024	9
Synthetic cannabinoid use and the acquired preparedness model	9
Emotional regulation in Gaming Disorder: A systematic review	9
Prevalence of problematic Internet use and its association with quality of life among undergraduate nursing students in the later stage of COVID‐19 pandemic era in China	9
Tobacco use and impulsivity in people with mental illness: A systematic review	9
AM Registration Flyer	9
Call for review papers 2021	8
Does cyber dating abuse victimization predict next‐day alcohol and cannabis use among college students?	8
Call for Special Issue Papers 2024	8
Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study	8
Issue Information ‐ ToC	7
Preconference On‐Demand availability	7
Exploring cannabis as a treatment for chronic pain in a rural Appalachian population	7
Issue Information ‐ Editorial Board	7
AAAP Podcast EP	6
Issue Information ‐ Editorial Board	6
Issue Information	6
AJA Annual Meeting 2023	6
	6
AAAP AATT Preconference	6
Call for review papers 2022	6
AAAP Call for Abstracts	5
AAAP annual meeting and pre‐conference courses	5
An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications	5
Health care service utilization and drug overdose death: A national nested case–control registry study	5
AAAP's Performance in practice activities	5
Posttraumatic stress disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical correlates	5
Issue Information ‐ ToC	5
2023 Advanced Addiction Psychopharmacology Course	5
Personality predicting relapse: A facet analysis of the NEO PI‐R	5
Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid us	5
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study	5
Issue Information ‐ Editorial Board	5
Stand Against Stigma	5
Extended‐release buprenorphine in pregnancy	5
FREE Live Webinar Psychotherapy Series: CAMS Approach to Suicidal Risk ‐ David A. Jobes, PhD, ABPP (Aug 13, 2025)	4
Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis‐induced psychosis: A longitudinal study	4
State‐level racial and ethnic disparities in buprenorphine treatment duration in the United States	4
AJA AM Save the Date 2023	4
Call for special issue 2023	4
Addiction specialists' attitudes toward psychedelics: A National Survey	4
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder	4
A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting	4
	4
Call for Symposium Abstracts	4
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs	4
Registration open – AAAP annual meeting and pre‐conference courses	4
Call for Special Issue 2023	4
Cannabis Use Disorders Performance in Practice	4

2023 Addictions and Their Treatment Course	4
AJA AM save the date 2023	3
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users	3
Issue Information ‐ Editorial Board	3
	3
Save the Date ‐ Annual Meeting 2025	3
AAAP Podcast Episode 10: A Discussion On Cybersecurity With Norma Krayem	3
2021 AJA Reviewer List	3
Severe gamma‐hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series	3
Stand Against Stigma	3
Mini‐Symposia I	3
Medical Update	3
Psychotherapy Webinar Series AJA	3
	3
Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort	3
AAAP Membership benefits	3
The relationship between depressed affect, parental monitoring, and sex on cannabis use among American Indian youth	3
AAAP 2024 Self‐Assessment Exam Now Available	3
Medication Management for Stimulant Use Disorder Webinar	2
AAAP on‐demand educational activities	2
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders	2
Trends in substance use disorder diagnoses among Veterans, 2009–2019	2
2025 Call for Symposium Abstracts	2
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review	2
Call for review papers 2022	2
Addiction Psychiatry Advanced Psychotherapy Curriculum	2
Concurrent Paper Sessions	2
Gambling, tobacco use, and health among individuals in substance use disorder treatment	2
Become an AAAP Member	2
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study	2
Paper sessions	2
Daily cannabis use may cause cannabis‐induced hyperalgesia	2
Call for special issue 2023	2
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem	2
Issue Information ‐ Editorial Board	2
Brief Report: Expectancies for alcohol analgesia are associated with greater alcohol use among moderate‐to‐heavy drinkers without chronic pain	2
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic	2
Call for Review Papers 2023	2
ORN Advancing racial equity	2
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients	2
Cannabis Use PIP Ad	2
32nd AAAP Annual meeting & scientific symposium recap	1
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization	1
Educating the community about the opioid epidemic and medications for opioid use disorder	1
Cannabis and the overdose crisis among US adolescents	1
PCSS exchange AJA Ad	1
Legalization of cannabis in Canada—Local media analysis	1
2023 Advanced Addiction Psychopharmacology Course	1
Symposium I	1
2024 Annual Meeting Posters	1
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study	1
AJA Psychedelics	1
AJA Annual Meeting 2024	1
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis	1
Examining family member characteristics by treatment status of the relative with substance use problems	1
Opioid overdose prevention and response training for medical students: Does training provide a benefit beyond the traditional curriculum, and are the gains of early training maintained?	1
AAAP ORN PIP ad	1
Opioid use disorder in the active service: Implications for intervention	1
Call for special issue 2023	1
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center	1
AAAP Membership	1
Call for special issue 2023	1
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students	1
Issue Information	1
Medical Update	1
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder	1
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex	1
Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate‐to‐severe alcohol use disorder	1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics	1
Issue Information ‐ ToC	1
Addiction Psychiatry Advanced Psychotherapy Curriculum	1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting	1
Film & Media Workshop	1
Mini‐Symposia II	1
Symposium III	1
AAAP Advanced Addiction Psychopharmacology Virtual Course, October 5‐6, 2024	1
Conference Schedule	1
Program title youth substance use and addiction timely updates on a critical issue	1
Understanding the role of cannabis use on cigarette dependence severity among individuals with e‐cigarette and combustible tobacco dual use	1
Issue Information	0

Addictions & Their Treatment Virtual Course, Sep 13‐14, 2024 ‐ 50% Discount Preconference 50% Off 2023 Self Assessment Exam	0
Motives for prescription opioid use: The role of alexithymia and distress tolerance	0
Travel Award AJA	0
FREE Online Self‐Assessment Exam: ORN StUD Performance in Practice (PIP)	0
Call for special issue 2021	0
	0
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O	0
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths	0
Identifying treatment responders to the combination of varenicline and naltrexone	0
Motivational Interviewing PIP	0
Issue Information	0
Call for review papers 2023	0
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey	0
Symposium IV	0
Issue Information ‐ Editorial Board	0
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder	0
PCSS is here to help!	0
Addiction Psychiatry Advanced Psychotherapy Session, September 11, 2024	0
Call for Review Papers 2024	0
AAAP's Educational Offerings	0
Binge drinking and sexual risk behavior among US sexual and gender minority college students	0
Estimating the effects of prenatal cannabis exposure on birth outcomes	0
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder	0
Opioid use disorder and its association with self‐reported difficulties participating in social activities	0
ORN Consultant Recruitment ‐ Join A National Public Health Alliance	0
Psychotherapy Webinar Series AJA	0
AAAP Podcast	0
Issue Information	0
	0
Motivational Interviewing Performance in Practice	0
Response to commentary, from Bisol et al., on “Tobacco use and impulsivity in people with mental illness: A systematic review,” Praecht, A. et al. (2025). Am. J. Addict. 34–4: 383–403	0
Film & Media Workshop	0
	0
Symposia, Medical Update, and Case Conference	0
Call for Special Issue 2022	0
Essential components of physician health program monitoring for substance use disorder: A survey of participants 5 years post successful program completion	0
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?	0
Medical marijuana access and prolonged opioid use among adolescents and young adults	0
Symposium II	0
Is your AAAP membership expiring soon?	0
Gender differences in the prevalence of stimulant misuse in the United States: 2015–2019	0
Stand against stigma	0
Conference Schedule	0
Call for review papers 2023	0
AAAP Travel Awards Open	0
Discrimination experiences and problematic alcohol and cannabis use in young adulthood	0
AJA psychedelic Ad	0
Issue Information	0
CSAM‐SMCA 2022 Scientific conference and annual meeting	0
Serum brain‐derived neurotrophic factor in relation to craving and duration of abstinence in patients with heroin dependence—A case‐control study	0
Become a AAAP Member	0
Issue Information ‐ Editorial Board	0
Absorption of naloxone in patients prescribed buprenorphine‐naloxone	0
Trajectories of prescription opioid and heroin use in adulthood	0
2024 Reviewer List	0
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial	0
Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross‐sectional study in Japan	0
AAAP Psychotherapy Curriculum Series	0
AAAP conference awards are open!	0
Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)	0
AAAP Performance and Practice (PIP) Resources	0
Predictors of protein intake among people who inject drugs in Los Angeles and San Francisco, California	0
A complex psychosocial portrait of substance use disorders among Indigenous people in the United States: A scoping review	0
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?	0
AAAP_Call for Review papers‐2024	0
Registration Open Now: Virtual Courses on Addictions and Their Treatment (Sep 12–13, 2025) and Advanced Addiction Psychopharmacology (Sep 20–21, 2025)	0
CSAM 2021 scientific conference	0
Issue Information ‐ ToC	0
AAAP podcast	0
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial	0
An examination of cannabis use motives among couples with intimate partner violence and alcohol use disorder	0
FREE Training & Mentoring: PCSS and ORN	0
Issue Information ‐ Editorial Board	0
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US	0
2022 Self‐Assessment examination	0
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder	0
Issue Information	0
Issue Information	0
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment	0
Become A AAAP Member!	0
AAAP PIPS 2023	0
Levels of engagement among office‐based opioid treatment (OBOT) patients with concurrent methamphetamine use	0
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program	0
Reasons for electronic cigarette use: Differences based on sex and young adult status	0
	0
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?	0
Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients	0
Issue Information	0
2023 Reviewer List (n = 223)	0
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study	0
	0
Call for review papers 2022	0
Managing Opioid Use Disorder Care in the Era of Fentanyl	0
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience	0
Become a AAAP Member	0